我院2012年1月-2014年12月门诊治疗儿童支气管哮喘药物利用分析

Analysis of drug use in children with bronchial asthma of January 2012-December 2014 in our hospital

目的 了解我院门诊治疗儿童支气管哮喘药物的应用情况,为临床合理用药提供参考。方法 利用我院信息系统,调取我院2012年1月-2014年12月门诊治疗儿童支气管哮喘药物销售金额、用药频度（DDDs）、日均费用（DDC）等进行统计分析。结果 三年来我院门诊治疗儿童支气管哮喘药物的总销售金额、DDDs均呈上升趋势;β2受体激动剂和糖皮质激素两类药始终居于前两位。结论 β2受体激动剂和糖皮质激素为我院三年来门诊治疗儿童支气管哮喘的主要药物,气雾剂和雾化液为主要剂型,雾化吸入疗法是门诊治疗儿童支气管哮喘的基本疗法。

Objective To explore the drug use in our hospital for children bronchial asthma,and provide reference for clinical medicine. Methods Using information system in our hospital, retrieved from January 2012 to December 2014 in our hospital,the consumption sum, DDDs and average daily cost（DDC） were statistically analyzed. Results The total sales amount and DDDs showed a rising trend; the top two drugs were β2 agonists and corticosteroids. Conclusion In our hospital for the past three years, β2 agonists and corticosteroids are the main drugs used in children with bronchial asthma, aerosol and spray liquid are the main form, inhalation therapy is the basic route.